Gainers
- Avenue Therapeutics, Inc. (NASDAQ:ATXI) jumped 78.5% to close at $0.6066 on Tuesday after jumping 36% on Monday.
- CTI BioPharma Corp. (NASDAQ:CTIC) surged 63.2% to close at $3.10 after the company announced FDA accelerated approval of VONJO for the treatment of adult patients with myelofibrosis and thrombocytopenia.
- GBS Inc. (NASDAQ:GBS) gained 50% to close at $0.69 after declining around 9% on Monday.
- Guardion Health Sciences, Inc. (NASDAQ:GHSI) surged 47.8% to close at $0.28. Guardion Health Sciences, last month, priced its $11 million public offering.
- CooTek (Cayman) Inc. (NYSE:CTK) gained 36.2% to settle at $0.3203.
- Trevi Therapeutics, Inc. (NASDAQ:TRVI) surged 36.1% to close at $0.8711. Trevi Therapeutics recently announced positive interim analysis results from Phase 2 CANAL trial of Haduvio (nalbuphine ER) in idiopathic pulmonary fibrosis patients (IPF) suffering from chronic cough.
- Sky Harbour Group Corporation (NYSE:SKYH) gained 30.8% to settle at $15.23.
- GWG Holdings, Inc. (NASDAQ:GWGH) jumped 29.4% to close at $5.33.
- Avinger, Inc. (NASDAQ:AVGR) jumped 28.3% to settle at $0.3336. Avinger recently reported successful completion of first cases with Lightbox 3 next generation imaging console.
- Blonder Tongue Laboratories, Inc. (NYSE:BDR) gained 27.9% to close at $0.55. Blonder Tongue Laboratories recently announced next generation DRAKE PEG encoder line.
- UserTesting, Inc. (NYSE:USER) shares surged 27.3% to settle at $10.59 after the company reported better-than-expected Q4 EPS and sales results. The company also issued Q1 and FY22 EPS and sales guidance above analysts’ estimates.
- Mmtec, Inc. (NASDAQ:MTC) gained 26.2% to close at $0.5740.
- Oak Street Health Inc (NYSE:OSH) jumped 23.5% to close at $21.63. Oak Street reported FY21 revenue of $1.43 billion.
- Marker Therapeutics, Inc (NASDAQ:MRKR) gained 22.3% to settle at $0.46.
- iQIYI, Inc. (NASDAQ:IQ) shares jumped 21.5% to close at $5.03 after the company reported fourth-quarter FY21 revenue of $1.2 billion, flat year-on-year, beating the consensus of $1.15 billion.
- InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) surged 21.3% to settle at $0.3702.
- Stabilis Solutions, Inc (NASDAQ:SLNG) gained 20.8% to close at $5.81.
- X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) surged 20% to close at $1.80.
- Danimer Scientific Inc (NASDAQ:DNMR) gained 19.9% to close at $4.77 following narrower-than-expected quarterly loss.
- Workhorse Group Inc. (NASDAQ:WKHS) surged 19.5% to close at $3.74 after the company reported Q4 results. The company said it expects to sell at least 250 vehicles in 2022 and generate at least $25 million in revenue.
- American Rebel Holdings, Inc. (NASDAQ:AREB) jumped 18.8% to close at $1.58. American Rebel recently reported closing of $10.5 million public offering.
- Tiziana Life Sciences PLC (NASDAQ:TLSA) gained 18.6% to settle at $0.7710. Tiziana Life Sciences recently highlighted submission of amendment for investigational new drug application to advance oral foralumab for Crohn's Disease.
- New Pacific Metals Corp. (NASDAQ:NEWP) jumped 18.6% to close at $3.64. New Pacific Metals, last month, posted Q2 loss of $0.01 per share.
- NeuBase Therapeutics, Inc (NASDAQ:NBSE) gained 18.2% to close at $1.75.
- Arcimoto, Inc (NASDAQ:FUV) surged 17% to close at $6.88. Arcimoto and Susie's Mopeds, an experience rental company in Friday Harbor, Washington, plan to begin demo rentals of Arcimoto Fun Utility Vehicles on San Juan Island beginning in March.
- Ra Medical Systems, Inc.</b> (NYSE:RMED) rose 17% to settle at $0.4998. Ra Medical Systems filed 510(k) application for the DABRA catheter with braided overjacket and six-month shelf life.
- AnPac Bio-Medical Science Co., Ltd. (NASDAQ:ANPC) surged 16.9% to settle at $0.77.
- New Fortress Energy Inc.(NYSE:NFE) gained 16.9% to close at $32.25 after the company reported better-than-expected Q4 sales results.
- Summit Therapeutics Inc. (NASDAQ:SMMT) gained 16.8% to close at $3.20. Summit Therapeutics recently reported postponement of its planned rights offering.
- TaskUs, Inc. (NASDAQ:TASK) gained 16.2% to close at $33.37 after the company reported better-than-expected Q4 adjusted EPS and sales results and issued FY22 sales guidance above estimates.
- LivePerson, Inc. (NASDAQ:LPSN) rose 16% to close at $23.52. Starboard Value raised its stake in LivePerson from 8.5% to 9.7%.
- Veritiv Corporation (NYSE:VRTV) jumped 15.6% to close at $123.92 after the company posted upbeat quarterly results.
- BP Prudhoe Bay Royalty Trust (NYSE:BPT) rose 15.4% to close at $14.55 as the Russia-Ukraine conflict caused supply concerns.
- Redbox Entertainment Inc. (NASDAQ:RDBX) surged 15.4% to close at $2.17.
- Freshpet, Inc.</b> (NASDAQ:FRPT) gained 15.2% to settle at $109.74 after the company issued FY22 sales guidance above analysts’ estimates.
- AVITA Medical, Inc. (NASDAQ:RCEL) gained 14.9% to close at $10.57 following Q2 results.
- Dogness (International) Corporation (NASDAQ:DOGZ) surged 14.5% to close at $3.24.
- Humanigen, Inc. (NASDAQ:HGEN) rose 14.3% to close at $2.32. Humanigen recently reported a FY21 net loss of $4.04 per share.
- Quantum-Si Inc (NASDAQ:QSI) gained 13.5% to close at $4.72 following Q4 results.
- Cano Health, Inc. (NYSE:CANO) rose 9.9% to close at $5.35. Cano Health delayed Q4 earnings release and conference call.
- Target Corporation (NYSE:TGT) climbed 9.8% to close at $219.43 after the company reported better-than-expected Q4 EPS results and issued FY22 guidance.
- Ucommune International Ltd (NASDAQ:UK) shares gained 8.3% to close at $0.4397 after dipping around 17% on Monday.
Check out this: Insiders Sell Around $16M Of 4 Stocks
Losers
- Vroom, Inc. (NASDAQ:VRM) dropped 46.6% to settle at $3.25 after the company reported worse-than-expected Q4 EPS results.
- Mullen Automotive, Inc. (NASDAQ:MULN) fell 39.1% to close at $1.03 after gaining over 145% on Monday. Mullen Automotive recently announced progress on solid-state polymer battery pack development.
- GoodRx Holdings, Inc. (NASDAQ:GDRX) shares tumbled 38.9% to close at $16.74 on Tuesday after the company reported worse-than-expected Q4 EPS and sales results and issued Q1 sales guidance below estimates.
- Imperial Petroleum Inc. (NASDAQ:IMPP) fell 37.6% to close at $1.48.
- Check-Cap Ltd. (NASDAQ:CHEK) dropped 37% to settle at $0.3870 after the company announced a $10 million registered direct offering.
- ZimVie Inc. (NASDAQ:ZIMV) dipped 32.8% to close at $25.53. Credit Suisse initiated coverage on ZimVie with an Underperform rating and announced a price target of $34.
- Ambarella, Inc. (NASDAQ:AMBA) fell 31.3% to close at $95.98 after the company reported Q4 earnings results and issued guidance.
- Semler Scientific, Inc. (NASDAQ:SMLR) dipped 27.9% to close at $52.64 after the company reported Q4 EPS and sales results down from last year.
- VEON Ltd. (NASDAQ:VEON) dropped 26.3% to close at $0.38. VEON recently reported Q4 earnings results.
- DSS, Inc. (NYSE:DSS) shares fell 23.1% to close at $0.4352 after jumping 47% on Monday.
- Endo International plc (NASDAQ:ENDP) dropped 22.5% to close at $2.41 after the company reported Q4 earnings results.
- Sidus Space, Inc. (NASDAQ:SIDU) fell 22% to close at $4.18.
- Atara Biotherapeutics, Inc. (NASDAQ:ATRA) dropped 20.5% to close at $10.21 after the company reported worse-than-expected Q4 EPS results.
- Indonesia Energy Corporation Limited (NASDAQ:INDO) dipped 20.2% to settle at $10.78.
- Zeta Global Holdings Corp. (NYSE:ZETA) fell 19.9% to settle at $10.42.
- James River Group Holdings, Ltd. (NASDAQ:JRVR) dropped 19.5% to close at $21.41 after the company reported Q4 EPS results down from last year.
- Paya Holdings Inc. (NASDAQ:PAYA) fell 19.5% to close at $5.19 following Q4 results.
- China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) fell 19.5% to close at $0.1730 in pre-market trading after jumping 45% on Monday.
- Intellia Therapeutics, Inc. (NASDAQ:NTLA) fell 19.2% to close at $79.85. Eight months after delivering promising biomarker data from one of the first CRISPR trials, Intellia Therapeutics presented additional data from the Phase 1 trial for NTLA-2001 in transthyretin, or ATTR, amyloidosis.
- MBIA Inc. (NYSE:MBI) dipped 19% to settle at $12.35 after the company reported worse-than-expected Q4 EPS results.
- Heron Therapeutics, Inc. (NASDAQ:HRTX) dropped 18.9% to close at $5.76 after the company reported worse-than-expected Q4 sales results.
- Core Scientific, Inc. (NASDAQ:CORZ) fell 18.6% to close at $7.49.
- NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) dropped 18.1% to close at $2.13. NeuroSense Therapeutics was granted patent for its ALS drug PrimeC in Australia.
- Vallon Pharmaceuticals, Inc. (NASDAQ:VLON) dipped 17.6% to close at $6.09. Vallon Pharmaceuticals recently announced issuance of US patent covering ADAIR for treatment of cognitive impairment associated with COVID-19.
- Albireo Pharma, Inc. (NASDAQ:ALBO) dropped 17.3% to settle at $27.57 after the company reported Q4 earnings results.
- PubMatic, Inc. (NASDAQ:PUBM) shares fell 17.2% to close at $25.35 after the company issued Q1 sales guidance below estimates.
- Werewolf Therapeutics, Inc. (NASDAQ:HOWL) dipped 15.9% to close at $6.02.
- BigCommerce Holdings, Inc. (NASDAQ:BIGC) fell 15.6% to close at $21.85 after the company reported worse-than-expected Q4 adjusted EPS results and issued guidance.
- Kyndryl Holdings, Inc. (NYSE:KD) dropped 14.8% to close at $13.50 after the company reported Q4 earnings results and said it sees Q1 sales down roughly 5%.
- Ranpak Holdings Corp. (NYSE:PACK) fell 14.8% to close at $20.61.
- Ranpak recently reported Q4 earnings results.
- Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) dropped 14.8% to close at $28.04.
- eHealth, Inc. (NASDAQ:EHTH) fell 14.6% to close at $13.27 after the company reported worse-than-expected Q4 sales results.
- Shift Technologies, Inc. (NASDAQ:SFT) dropped 14.4% to close at $1.73.
- CSP Inc. (NASDAQ:CSPI) fell 14.3% to close at $7.07.
- International Game Technology PLC (NYSE:IGT) dropped 13.9% to close at $26.37 following Q4 results.
- Lucid Group, Inc. (NASDAQ:LCID) fell 13.8% to close at $24.99 after the company reported worse-than-expected Q4 sales results and cut FY22 production guidance.
- ON24, Inc. (NYSE:ONTF) dipped 12.4% to close at $13.67 after the company issued Q1 and FY22 guidance below analyst estimates.
- Groupon, Inc. (NASDAQ:GRPN) shares fell 7.7% to close at $20.05 after the company reported worse-than-expected Q4 EPS and sales results and issued Q1 sales guidance below estimates.
Also check this out: Eli Lilly And 3 Other Stocks Sold By Insiders.
